<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="antiviral1\PMC4531042\results\search\drugs\results.xml">
  <result pre="to minimize immunosuppression. The current antiviral drugs against CMV, ie," exact="ganciclovir" post="(GCV), foscarnet (PFA), and cidofovir (CDV), are associated with"/>
  <result pre="antiviral drugs against CMV, ie, ganciclovir (GCV), foscarnet (PFA), and" exact="cidofovir" post="(CDV), are associated with significant adverse effects. Moreover, there"/>
  <result pre="treatment are the nucleoside analog GCV, and its valine-ester prod-rug" exact="valganciclovir" post="(VGCV), the nucleotide analog CDV, and the pyrophosphate analog"/>
  <result pre="CMV-related disease. Often, transplant patients are receiving other drugs (eg," exact="tacrolimus" post="and calcineurin inhibitors) that augment the risk for renal"/>
  <result pre="specific sites where viral DNA will be cleaved; it produces" exact="adenosine" post="triphosphate (ATP) necessary for DNA translocation; and it combines"/>
  <result pre="CMV disease with 240 mg daily of letermovir was on" exact="tacrolimus" post="as part of his immunosuppression regimen, and no dose"/>
  <result pre="Infect Dis20094981167116819751150 5HumarALebranchuYVincentiFet al.The efficacy and safety of 200 days" exact="valganciclovir" post="cytomegalovirus prophylaxis in high-risk kidney transplant recipientsAm J Transplant20101051228123720353469"/>
  <result pre="kidney transplant recipientsAm J Transplant20101051228123720353469 6PayaCHumarADominguezEet al.Efficacy and safety of" exact="valganciclovir" post="vs oral ganciclovir for prevention of cytomegalovirus disease in"/>
  <result pre="J Transplant20101051228123720353469 6PayaCHumarADominguezEet al.Efficacy and safety of valganciclovir vs oral" exact="ganciclovir" post="for prevention of cytomegalovirus disease in solid organ transplant"/>
  <result pre="(only moderate increases in the levels of midazolam, tacrolimus, and" exact="cyclosporine" post="were observed among healthy volunteers) McCormick48 Potential future applications"/>
 </snippets>
</snippetsTree>
